These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis. Cohanim M; Yendt ER Invest Urol; 1980 Sep; 18(2):170-3. PubMed ID: 7410033 [TBL] [Abstract][Full Text] [Related]
23. [Recent progress in therapy of urinary calculi]. Yatake T Hokkaido Igaku Zasshi; 1987 May; 62(3):362-5. PubMed ID: 3301611 [No Abstract] [Full Text] [Related]
24. [Nephrolithiasis in hypercalciuria and hyperparathyroidism]. Rapado A; de la Calle H; Castrillo JM; Mancha A; Traba ML; Delatte LC MMW Munch Med Wochenschr; 1976 Jun; 118(25):799-810. PubMed ID: 819807 [TBL] [Abstract][Full Text] [Related]
25. A thermodynamic equilibrium model for calcium salt urolithiasis: clinical application. Ashby R; Györy AZ Exp Nephrol; 1997; 5(3):246-52. PubMed ID: 9208285 [TBL] [Abstract][Full Text] [Related]
27. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones. Ritz E; Schmidt-Gayk H; Möhring K Eur Urol; 1975; 1(3):131-3. PubMed ID: 183957 [TBL] [Abstract][Full Text] [Related]
28. [Therapy of nephrolithiasis]. Tschöpe W; Ritz E Dtsch Med Wochenschr; 1985 Mar; 110(10):385-8. PubMed ID: 3971867 [No Abstract] [Full Text] [Related]
31. Symposium on renal lithiasis. Renal lithiasis in review. Finlayson B Urol Clin North Am; 1974 Jun; 1(2):181-212. PubMed ID: 4372765 [No Abstract] [Full Text] [Related]
32. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats. Bushinsky DA; Asplin JR J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340 [TBL] [Abstract][Full Text] [Related]
33. [Efficacy of drug prophylaxis in calcium urolithiasis]. Yamaguchi K; Takahara M; Amakasu M; Miyauchi T; Murakami M; Ito H; Shimazaki J Nihon Hinyokika Gakkai Zasshi; 1986 Jul; 77(7):1177-81. PubMed ID: 3784206 [No Abstract] [Full Text] [Related]
34. The benefits of evaluation of the patient with recurrent or multiple calcium stones. Peterson LJ; Hruska KA J Urol; 1979 Jun; 121(6):766-8. PubMed ID: 458948 [TBL] [Abstract][Full Text] [Related]
35. [Is it necessary to systematically reduce dietary calcium intake in lithiasic patients?]. Fuss M; Van Geel J; Pepersack T; Bergmann P; Van de Walle JC; Simon J Acta Urol Belg; 1988; 56(4):511-5. PubMed ID: 3207083 [No Abstract] [Full Text] [Related]
36. Prevention of calcium stones with thiazides. Yendt ER; Cohanim M Kidney Int; 1978 May; 13(5):397-409. PubMed ID: 351268 [TBL] [Abstract][Full Text] [Related]
37. Hydration properties of urinary compounds obtained from normal and stone former individuals. An NMR study. Azoury R; Weininger J; Iaina A; Abrashkin S J Urol; 1988 May; 139(5):1111-4. PubMed ID: 3361655 [TBL] [Abstract][Full Text] [Related]
38. [Hyperparathyroidism in urology today. New etiopathogenetic, diagnostic and therapeutic acquisitions]. Giuliani L; Carmignani G; Belgrano E; Puppo P; Cichero A; Repetto U Minerva Urol; 1980; 32(3):133-52. PubMed ID: 6776394 [No Abstract] [Full Text] [Related]
39. [Conservative therapy of phosphate calculi]. Lycklama à Nijeholt AA; Jonas U Urologe A; 1984 Mar; 23(2):91-4. PubMed ID: 6539026 [TBL] [Abstract][Full Text] [Related]